Your browser doesn't support javascript.
loading
The Feasibility of Quality Assurance in the TOPGEAR International Phase 3 Clinical Trial of Neoadjuvant Chemoradiation Therapy for Gastric Cancer (an Intergroup Trial of the AGITG/TROG/NHMRC CTC/EORTC/CCTG).
Lukovic, Jelena; Moore, Alisha J; Lee, Mark T; Willis, David; Ahmed, Shahida; Akra, Mohamed; Hortobagyi, Eszter; Kron, Tomas; Lim Joon, Daryl; Liu, Amy; Ryan, John; Thomas, Melissa; Wall, Katelyn; Ward, Iain; Wiltshire, Kirsty L; O'Callaghan, Chris J; Wong, Rebecca K S; Ringash, Jolie G; Haustermans, Karin; Leong, Trevor.
Afiliación
  • Lukovic J; Radiation Medicine Program, Princess Margaret Cancer Centre and Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada. Electronic address: jelena.lukovic@rmp.uhn.ca.
  • Moore AJ; Trans-Tasman Radiation Oncology Group, University of Newcastle, Newcastle, New South Wales, Australia.
  • Lee MT; Liverpool and Macarthur Cancer Therapy Centre, Sydney, New South Wales, Australia.
  • Willis D; Cancer Care Services, Sunshine Coast University Hospital, Birtinya, Queensland, Australia.
  • Ahmed S; Radiation Oncology, CancerCare Manitoba, Department of Radiology, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Akra M; Radiation Oncology, CancerCare Manitoba, Department of Radiology, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Hortobagyi E; Department of Radiation Oncology, UZ Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
  • Kron T; Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.
  • Lim Joon D; Department of Radiation Oncology, Olivia Newton-John Cancer Centre, Melbourne, Victoria, Australia; Department of Medical Imaging and Radiation Sciences, Monash University, Melbourne, Victoria, Australia.
  • Liu A; Radiation Medicine Program, Princess Margaret Cancer Centre and Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
  • Ryan J; Department of Medical Imaging and Radiation Sciences, Monash University, Melbourne, Victoria, Australia.
  • Thomas M; Department of Radiation Oncology, UZ Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
  • Wall K; Department of Radiation Oncology, North West Cancer Centre, Tamworth, New South Wales, Australia.
  • Ward I; St. George's Cancer Care, Christchurch, New Zealand.
  • Wiltshire KL; Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.
  • O'Callaghan CJ; Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada.
  • Wong RKS; Radiation Medicine Program, Princess Margaret Cancer Centre and Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
  • Ringash JG; Radiation Medicine Program, Princess Margaret Cancer Centre and Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
  • Haustermans K; Department of Radiation Oncology, UZ Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
  • Leong T; Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.
Int J Radiat Oncol Biol Phys ; 117(5): 1096-1106, 2023 Dec 01.
Article en En | MEDLINE | ID: mdl-37393022
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Revista: Int J Radiat Oncol Biol Phys Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Revista: Int J Radiat Oncol Biol Phys Año: 2023 Tipo del documento: Article